UCLA Scientists Develop One-Product-Fits-All Immunotherapy for Breast Cancer
October 22, 2025
October 22, 2025
LOS ANGELES, California, Oct. 22 (TNSjou) -- The UCLA Health issued the following news release:
* * *
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies.
UCLA researchers have developed a novel therapy that could fun . . .
* * *
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies.
UCLA researchers have developed a novel therapy that could fun . . .